MRSN — Mersana Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Mersana Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	255	178	281	209	135
Net Total Accounts Receivable
Net Total Receivables	—	—	30	0	—
Prepaid Expenses
Total Current Assets	259	189	319	214	137
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.7	14.9	14.5	11.5	6.78
Other Long Term Assets
Total Assets	273	206	334	226	145
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30	47.5	91.5	63.6	62.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	45.3	84.4	242	189	154
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	228	122	92.1	36.9	-9.51
Total Liabilities & Shareholders' Equity	273	206	334	226	145
Total Common Shares Outstanding